Newsletter

Fibrodysplasia Ossificans Progressiva
With no cure at hand Pharma companies gear up to offer relief to patients suffering from a sporadic connective tissue disease.
Fibrodysplasia Ossificans Progressiva

More Whitepapers / Newsletters

Cancer Care in the time of COVID
Cancer Care in the time of COVID

The coronavirus outbreak has affected thousands of people in at least 186 countries which has also affected the cancer care delivery system apart from affecting the overall health system.....

Healthcare Performance Whitepaper
Healthcare Performance Whitepaper

Healthcare Performance Improvement provides proven methods for sustaining and building a culture of safety. In order to build a new...

Pompe disease Newsletter
Pompe disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen..

ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies Whitepaper
ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies

Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from cancer help...

Digital Health Transformation: 2020 Roadmap for Innovation Whitepaper
Digital Health Transformation: 2020 Roadmap for Innovation Whitepaper

The Digital Era has officially hit Prime Time. Currently, the potentiality to digitally transform a patient's healthcare service experience is becoming a significant competitive....